Federal award (DELIVERY ORDER, fiscal year 2024)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2025-09-10 to 2025-09-11
Current total value of award: $2217.66
Description: 4569417493!QUILLIVANT XR 25 MG/5 ML SUSP 120ML